The active magnetic resonance imaging stent (AMRIS): initial experimental in vivo results with locally amplified MR angiography and flow measurements

Invest Radiol. 2001 Nov;36(11):625-31. doi: 10.1097/00004424-200111000-00001.

Abstract

Rationale and objectives: Magnetic resonance (MR) is limited by artifacts in vessels after stenting. An active MR imaging stent (AMRIS) allows for artifact-free imaging with local improvement in signal-to-noise ratio (SNR). In a rabbit model, we evaluated the imaging properties by MR angiography (MRA) and flow measurements.

Methods: The AMRIS was placed in the abdominal aorta of five rabbits. At 1.5 T, MRA (three-dimensional fast low-angle shot) was performed before and after intravenous injection of an iron oxide-based, blood-pool contrast medium (dose, 50 micromol Fe/kg), and flow measurements were performed (electrocardiographically triggered phase-contrast cine gradient-echo sequence). Mean SNRs were calculated and flow volume curves were generated.

Results: The SNR was 6.0 +/- 0.6 (outside the stent) versus 12.3 +/- 1.1 (inside the stent, P < 0.05) for plain MRA, 21.2 +/- 0.6 versus 40.6 +/- 5.2 (P < 0.05) for contrast-enhanced MRA, and 5.4 +/- 0.4 versus 13.7 +/- 2.1 (P < 0.05) for the magnitude images of flow measurements. Flow volume curves within and distal to the stent were comparable.

Conclusions: By using the AMRIS as a vascular stent, the stented vessel segment can be examined with enhanced signal intensity on MRI.

MeSH terms

  • Animals
  • Aorta, Abdominal / pathology*
  • Aorta, Abdominal / surgery
  • Artifacts
  • Blood Flow Velocity
  • Contrast Media / administration & dosage
  • Ferric Compounds
  • Ferrosoferric Oxide
  • Injections, Intravenous
  • Magnetic Resonance Angiography* / methods*
  • Male
  • Rabbits
  • Stents*

Substances

  • Contrast Media
  • Ferric Compounds
  • superparamagnetic blood pool agent
  • Ferrosoferric Oxide